CBN Activated Stress-Protection and Brain-Plasticity Genes in Neuronal Cells | Research

The takeaway

Cannabinol pre-treatment in neuronal cell cultures activated genes involved in cellular stress response and axon guidance without harming cell viability at any tested concentration.

neuroscience researchers, cannabinoid pharmacologists, neurodegenerative disease researchers

What the researchers found

CBN had no negative impact on cell viability at concentrations from 5 to 100 micromolar. Transcriptomic analysis showed significant enrichment in Reactome pathways for cellular response to stress, cellular response to stimuli, and axon guidance. These findings suggest CBN may modulate neuronal cell survival and plasticity-related processes.

Why it matters

CBN is a minor cannabinoid that has received far less research attention than CBD or THC. This transcriptomic study identifies specific gene pathways through which CBN may exert neuroprotective effects, informing future research directions.

The numbers in context

Five CBN concentrations tested: 5, 10, 20, 50, 100 micromolar. 24-hour pre-treatment. No viability reduction at any concentration. Three significantly enriched Reactome pathways: cellular response to stress, cellular response to stimuli, axon guidance.

How the study worked

Differentiated NSC-34 neuroblastoma/spinal cord cells were pre-treated with CBN at five concentrations (5, 10, 20, 50, 100 micromolar) for 24 hours. Transcriptomic analysis via next-generation sequencing with pathway enrichment analysis using the Reactome database.

What this study cannot tell us

In vitro study using an immortalized cell line, not primary neurons. No disease model or functional readout beyond gene expression. Single timepoint (24 hours). Gene expression changes do not necessarily translate to protein-level or functional effects.

How to read the evidence

In vitro transcriptomic study in an immortalized cell line without functional validation or disease model context places this firmly at preliminary.

When this study was published

Recently published laboratory research.

The bigger picture

While these findings are strictly in vitro, they add to a growing body of evidence that minor cannabinoids may have distinct biological activities worth exploring. The axon guidance finding is particularly interesting for neurodegenerative disease research.

Questions still open

Do these gene expression changes translate to neuroprotective effects in animal models?
What concentrations of CBN are achievable in the human brain?

Common questions

What is CBN?

Cannabinol (CBN) is a minor cannabinoid that forms naturally as THC ages and degrades. It has shown antioxidant, anti-inflammatory, and analgesic properties in previous research.

Could CBN help with brain diseases?

This cell study found CBN activates gene pathways related to stress protection and neural connectivity, which is promising but far from clinical application. Animal and human studies are needed.

Read the original research

Cannabinol's Modulation of Genes Involved in Oxidative Stress Response and Neuronal Plasticity: A Transcriptomic Analysis.

Antioxidants (Basel, Switzerland), 14(6)

View on PubMed ↗Publisher’s paper ↗

Citation

Silvestro, Serena; Calabrò, Marco; Trainito, Alessandra; Salamone, Stefano; Pollastro, Federica; Mazzon, Emanuela; Minuti, Aurelio. (2025). Cannabinol's Modulation of Genes Involved in Oxidative Stress Response and Neuronal Plasticity: A Transcriptomic Analysis.. Antioxidants (Basel, Switzerland), 14(6). https://doi.org/10.3390/antiox14060744